Source: The Pharma Letter

Lung Therapeutics: Lung Tx sells Japanese rights to orphan drug candidate

Tokyo's Taiho Pharmaceutical and Texas, USA-based Lung Therapeutics have agreed an exclusive license...

Read full article »
Lung Therapeutics's Competitors | Lung Therapeutics's News | Lung Therapeutics's Financials
Stay up-to-date with the latest news on Lung Therapeutics
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Brian Windsor's photo - CEO of Lung Therapeutics

CEO

Brian Windsor

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on Lung Therapeutics